Brian Rini

594 total citations
14 papers, 246 citations indexed

About

Brian Rini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Brian Rini has authored 14 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Brian Rini's work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (3 papers) and CAR-T cell therapy research (2 papers). Brian Rini is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Renal and related cancers (3 papers) and CAR-T cell therapy research (2 papers). Brian Rini collaborates with scholars based in United States, France and Austria. Brian Rini's co-authors include Jonathan S. Citow, Robert L. Wollmann, R. Loch Macdonald, Bernard Escudier, Nizar M. Tannir, Andrzej Deptała, Mayer Fishman, Rodryg Ramlau, Alain Ravaud and Cezary Szczylik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Brian Rini

14 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Rini United States	8	107	88	80	70	65	14	246
Chan Xiang China	12	167 1.6×	140 1.6×	124 1.6×	95 1.4×	47 0.7×	32	378
Donna C. Ferguson United States	7	91 0.9×	91 1.0×	50 0.6×	65 0.9×	23 0.4×	15	220
Valeria Maffeis Italy	11	81 0.8×	51 0.6×	93 1.2×	80 1.1×	162 2.5×	21	360
C. Massard France	11	141 1.3×	130 1.5×	55 0.7×	87 1.2×	29 0.4×	40	325
Sasha Beyer United States	10	83 0.8×	93 1.1×	105 1.3×	66 0.9×	46 0.7×	62	323
Shuichi Tsukamoto Japan	11	107 1.0×	106 1.2×	48 0.6×	132 1.9×	77 1.2×	23	333
Zhang Cheng China	9	90 0.8×	41 0.5×	87 1.1×	46 0.7×	36 0.6×	13	315
Toshimichi Tanaka Japan	13	197 1.8×	74 0.8×	70 0.9×	134 1.9×	110 1.7×	32	357
Nobuyoshi Takeuchi Japan	7	79 0.7×	69 0.8×	135 1.7×	69 1.0×	53 0.8×	25	322
Aiko Kurisaki‐Arakawa Japan	10	66 0.6×	182 2.1×	43 0.5×	79 1.1×	32 0.5×	17	331

Countries citing papers authored by Brian Rini

Since Specialization

Citations

This map shows the geographic impact of Brian Rini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Rini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Rini more than expected).

Fields of papers citing papers by Brian Rini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Rini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Rini. The network helps show where Brian Rini may publish in the future.

Co-authorship network of co-authors of Brian Rini

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Rini. A scholar is included among the top collaborators of Brian Rini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Rini. Brian Rini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kahramangil, Bora, Emin Köse, Erick M. Remer, et al.. (2020). A Modern Assessment of Cancer Risk in Adrenal Incidentalomas. Annals of Surgery. 275(1). e238–e244. 34 indexed citations

Mittal, Kriti, Lisa Derosa, Laurence Albigès, et al.. (2018). Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors. Clinical Genitourinary Cancer. 16(3). e663–e667. 11 indexed citations

Patil, Pradnya D., Anthony P. Fernandez, Vamsidhar Velcheti, et al.. (2018). Cases from the irAE Tumor Board: A Multidisciplinary Approach to a Patient Treated with Immune Checkpoint Blockade Who Presented with a New Rash. The Oncologist. 24(1). 4–8. 8 indexed citations

Schmidinger, Manuela, Romano Danesi, Robert J. Jones, et al.. (2017). Individualized Dosing with Axitinib: Rationale and Practical Guidance. Future Oncology. 14(9). 861–875. 14 indexed citations

Wei, Xiao X., Serena S. Kwek, Jera Lewis, et al.. (2016). Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer. Cancer Immunology Research. 4(11). 948–958. 30 indexed citations

Parekh, Hiral D., et al.. (2016). Axitinib for the Treatment of Metastatic Renal Cell Carcinoma. Future Oncology. 12(3). 303–311. 7 indexed citations

Najjar, Yana G., Patricia Rayman, Xuefei Jia, et al.. (2014). Accumulation of MDSC subsets in renal cell carcinoma correlates with grade and progression free survival, and is associated with intratumoral expression of IL-1β, IL-8 and CXCL5. Journal for ImmunoTherapy of Cancer. 2(S3). 2 indexed citations

Dreicer, Robert, Jorge García, Brian Rini, et al.. (2013). A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer. Investigational New Drugs. 31(4). 1044–1050. 13 indexed citations

Mittal, Kriti, Sapna Rawal, Zheng Ao, et al.. (2012). Detection of circulating tumor cells in advanced renal cell carcinoma patients using microfilter-based capture. Journal of Food Science. 80(12). S2944–9. 2 indexed citations

10.

Rini, Brian, Cezary Szczylik, Nizar M. Tannir, et al.. (2012). AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney. Cancer. 118(24). 6152–6161. 87 indexed citations

11.

Teh, Bin Tean, Daochao Huang, Yangping Ding, et al.. (2010). The mechanism of action and resistance of sunitinib in RCC.. Journal of Clinical Oncology. 28(15_suppl). e13606–e13606. 1 indexed citations

12.

Tamaskar, Ila, J. Garcia, Robert Dreicer, et al.. (2007). Thyroid function test (TFT) abnormalities in patients (pts) with metastatic renal cell carcinoma (RCC) treated with sorafenib. Journal of Clinical Oncology. 25(18_suppl). 5048–5048. 5 indexed citations

13.

Citow, Jonathan S., Brian Rini, Robert L. Wollmann, & R. Loch Macdonald. (2001). Isolated, Primary Extranodal Hodgkin's Disease of the Spine: Case Report. Neurosurgery. 49(2). 453–457. 31 indexed citations

14.

Citow, Jonathan S., Brian Rini, Robert L. Wollmann, & R. Loch Macdonald. (2001). Isolated, Primary Extranodal Hodgkin’s Disease of the Spine: Case Report. Neurosurgery. 49(2). 453–457. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact